Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
28 pending office actions • 13 clients • 28 examiners • 23 art units • 0 of 28 (0%) have an AI response strategy ready
NYEMASTER GOODE P.C. focuses on Biotechnology & Pharmaceuticals with 28 pending office actions and 1146 career applications. Its resolved allowance rate is 89.03%, indicating allowance in a substantial majority of resolved applications. The recorded application portfolio provides context for the open-action inventory, which reflects continuing prosecution activity.
The average of 3.66 office actions per allowance indicates that allowed matters commonly require several examination exchanges. Practitioners can use the measure to plan response resources while using the allowance rate to assess resolved outcomes. The profile supports structured docket oversight and matter-specific claim strategy across biotechnology and pharmaceutical applications.
Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (4%) |
| §101 + other | 1 (4%) |
| §103 only | 9 (32%) |
| §112 only | 2 (7%) |
| Double-patenting + other | 2 (7%) |
| Multi-statute (no §101) | 13 (46%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ENGLISH, PETER C | 1 | 33.5% | +26.9% |
| ARMSTRONG, KYLE | 1 | 72.0% | +29.6% |
| LOUNTOS, GEORGE THEMISTOCLIS | 1 | 57.1% | +60.0% |
| KIM, BRYAN | 1 | 28.2% | +36.6% |
| MARTIN, PAUL C | 1 | 41.8% | +21.7% |
| LIU, TRACY | 1 | 54.5% | +26.9% |
| FRONDA, CHRISTIAN L | 1 | 82.5% | +14.3% |
| BAKKAR, AYA ZIAD | 1 | 63.3% | +43.2% |
| BARRON, SEAN C | 1 | 52.7% | +30.4% |
| JOHNSON, DANIELLE D | 1 | 45.0% | +13.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18802964 | Screening Assays, Modulators and Modulation of Activation of Receptor for Advanced Glycation End-Products (RAGE) | FRONDA, CHRISTIAN L | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18020010 | LITHIATED SILICON | LI, JUN | 85d overdue |
| 17312317 | Screening Assays, Modulators and Modulation of Intracellular Signalling Mediated by Immunoglobulin Superfamily Cell Adhesion Molecules | WU, JULIE ZHEN QIN | 12d |
| 18230227 | USE OF BETA-1,3-GLUCAN FOR MODULATING IMMUNE FUNCTION AND TREATING INTESTINAL INFLAMMATION | GOTFREDSON, GAREN | 27d |
| 18741436 | Brace Having Interchangeable Therapeutic Modalities | RODRIQUEZ, KARI KRISTIN | 28d |
| 18195517 | SELF-EMULSIFYING ANHYDROUS INTRADERMAL DEPOT GEL | CHANDRAKUMAR, NIZAL S | 33d |
| 18432911 | ANIMAL FEED SUPPLEMENT | DUBOIS, PHILIP A | 56d |
| 19216471 | STRUCTURAL SOLAR ARCH | ENGLISH, PETER C | — |
| 18917924 | FEED ADDITIVE FOR IMPROVING ANIMAL PERFORMANCE, DIGESTION AND INTESTINAL HEALTH AND RELATED METHODS | KIM, BRYAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19216471 | STRUCTURAL SOLAR ARCH | ENGLISH, PETER C | — |
| 19171575 | DOCK SEGMENT COUPLING ASSEMBLY AND METHOD FOR USING | ARMSTRONG, KYLE | — |
| 19105022 | NOVEL POLYPEPTIDE WITH GLUCANASE ACTIVITY | LOUNTOS, GEORGE THEMISTOCLIS | — |
| 18917924 | FEED ADDITIVE FOR IMPROVING ANIMAL PERFORMANCE, DIGESTION AND INTESTINAL HEALTH AND RELATED METHODS | KIM, BRYAN | — |
| 18902290 | METHODS OF ADMINISTERING COMPOSITIONS OF BACILLUS SUBTILIS PB6, BUTYRIC ACID WITH ZINC, AND OPTIONALLY RED CLOVER, TO REDUCE LIVER ABSCESSES IN CATTLE | MARTIN, PAUL C | — |
| 18815432 | TEMPORARY TOOTH REPAIR/TREATMENT COMPOSITION AND METHODS OF USE THEREOF | LIU, TRACY | — |
| 18802964 | Screening Assays, Modulators and Modulation of Activation of Receptor for Advanced Glycation End-Products (RAGE) | FRONDA, CHRISTIAN L | — |
| 18800377 | LIGHT BASED DENTAL TREATMENT DEVICE | BAKKAR, AYA ZIAD | — |
| Client (Assignee) | Pending OAs |
|---|---|
| KEMIN INDUSTRIES, INC. | 14 |
| THE UNIVERSITY OF WESTERN AUSTRALIA | 2 |
| Moray Group, LLC | 2 |
| Vacuum Technologies, LLC | 1 |
| Walk On Water, Inc. | 1 |
| Orvance, LLC | 1 |
| DENTOSITY, LLC | 1 |
| YUR Brace | 1 |
| Taiyuan University of Technology | 1 |
| Medpharm Iowa, LLC | 1 |
| Renewable Energy Group, Inc. | 1 |
| MEDPHARM HOLDINGS, LLC | 1 |
| King's College London | 1 |
| Art Unit | Apps |
|---|---|
| 1652 | 2 |
| 1653 | 2 |
| 3753 | 2 |
| 1612 | 2 |
| 3993 | 1 |
| 3619 | 1 |
| 1614 | 1 |
| 3796 | 1 |
| 1617 | 1 |
| 3786 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19216471 | STRUCTURAL SOLAR ARCH | Vacuum Technologies, LLC | ENGLISH, PETER C | 3993 | §103§112Other | Non-Final OA | — | Pending | May 22, 2025 |
| 19171575 | DOCK SEGMENT COUPLING ASSEMBLY AND METHOD FOR USING | Walk On Water, Inc. | ARMSTRONG, KYLE | 3619 | §103 | Non-Final OA | — | Pending | Apr 07, 2025 |
| 19105022 | NOVEL POLYPEPTIDE WITH GLUCANASE ACTIVITY | Kemin Industries, Inc. | LOUNTOS, GEORGE THEMISTOCLIS | 1652 | §112 | Non-Final OA | — | Pending | Feb 19, 2025 |
| 18917924 | FEED ADDITIVE FOR IMPROVING ANIMAL PERFORMANCE, DIGESTION AND INTESTINAL HEALTH AND RELATED METHODS | Kemin Industries, Inc. | KIM, BRYAN | §103§112 | Non-Final OA | — | Pending | Oct 16, 2024 | |
| 18902290 | METHODS OF ADMINISTERING COMPOSITIONS OF BACILLUS SUBTILIS PB6, BUTYRIC ACID WITH ZINC, AND OPTIONALLY RED CLOVER, TO REDUCE LIVER ABSCESSES IN CATTLE | Kemin Industries, Inc. | MARTIN, PAUL C | 1653 | §103 | Non-Final OA | — | Pending | Sep 30, 2024 |
| 18815432 | TEMPORARY TOOTH REPAIR/TREATMENT COMPOSITION AND METHODS OF USE THEREOF | Orvance, LLC | LIU, TRACY | 1614 | §103§112 | Final Rejection | — | Pending | Aug 26, 2024 |
| 18802964 | Screening Assays, Modulators and Modulation of Activation of Receptor for Advanced Glycation End-Products (RAGE) | The University of Western Australia | FRONDA, CHRISTIAN L | 1652 | §103DP | Non-Final OA | — | Pending | Aug 13, 2024 |
| 18800377 | LIGHT BASED DENTAL TREATMENT DEVICE | Dentosity, LLC | BAKKAR, AYA ZIAD | 3796 | §103 | Non-Final OA | — | Pending | Aug 12, 2024 |
| 18794498 | METHOD AND SYSTEM FOR TREATEMNET OF MICROORGANISMS DURING PROPAGATION, CONDITIONING, FERMENTATION, AND PRESERVATION USING LAE AND SELECTED ADDITIVES | Kemin Industries, Inc. | BARRON, SEAN C | 1653 | §103 | Final Rejection | — | Pending | Aug 05, 2024 |
| 18766645 | COMPOSITIONS CONTAINING PEROXYACIDS TO CONTROL PATHOGEN GROWTH IN ANIMAL FEED AND RELATED METHODS | Kemin Industries, Inc. | JOHNSON, DANIELLE D | 1617 | §102§103§112 | Non-Final OA | — | Pending | Jul 08, 2024 |
| 18741436 | Brace Having Interchangeable Therapeutic Modalities | Yur Brace, LLC | RODRIQUEZ, KARI KRISTIN | 3786 | §102§103 | Non-Final OA | 28d | Pending | Jun 12, 2024 |
| 18444907 | ASSEMBLY AND METHOD FOR REPAIRING PIPE HAVING MORE COMPLETE LINER EXPANSION | Moray Group, LLC | AHMED, FAISAL | 3753 | §102§103 | Non-Final OA | — | Pending | Feb 19, 2024 |
| 18444965 | Light Train Centering Assembly and Method of Using | Moray Group, LLC | LEARY, JOSHUA DENNIS | 3753 | §102§103 | Non-Final OA | — | Pending | Feb 19, 2024 |
| 18432911 | ANIMAL FEED SUPPLEMENT | Kemin Industries, Inc. | DUBOIS, PHILIP A | 1791 | §103§112 | Final Rejection | 56d | Pending | Feb 05, 2024 |
| 18422533 | COPPER-ZINC ALLOY CATALYST, AND PREPARATION METHOD AND USE THEREOF | Taiyuan University Of Technology | JOHNSON, CHRISTINA ANN | 1742 | §102§112 | Non-Final OA | — | Pending | Jan 25, 2024 |
| 18230227 | USE OF BETA-1,3-GLUCAN FOR MODULATING IMMUNE FUNCTION AND TREATING INTESTINAL INFLAMMATION | Kemin Industries, Inc. | GOTFREDSON, GAREN | 1619 | §101DP | Non-Final OA | 27d | Pending | Aug 04, 2023 |
| 18221987 | PROCESS FOR PREPARING CANNABIS SUGAR WAX CONCENTRATE AND RELATED COMPOSITIONS AND METHODS | Medpharm Iowa, LLC | MOREAU, NASHARA LOUISE | 1655 | §103§112 | Non-Final OA | — | Pending | Jul 14, 2023 |
| 18211886 | INTRAOCULAR DELIVERY OF BIOACTIVE MOLECULES USING IONTOPHORESIS | Kemin Industries, Inc. | ABBAS, ABDULRAHMAN MUSTAFA | 1612 | §103DP | Non-Final OA | 72d overdue | Pending | Jun 20, 2023 |
| 18332327 | POLYOL TREATMENT OF HYDRODEOXYGENATION FEEDSTOCK | Renewable Energy Group, Inc. | CHONG, JASON Y | 1772 | §103§112 | Non-Final OA | — | Pending | Jun 09, 2023 |
| 18204197 | STABLE COATED CINNAMIC ALDEHYDE COMPOSITIONS FOR ANIMAL FEED AND RELATED METHODS | Kemin Industries, Inc. | DIVIESTI, KARLA ISOBEL | 1792 | §103 | Non-Final OA | — | Pending | May 31, 2023 |
| 18195517 | SELF-EMULSIFYING ANHYDROUS INTRADERMAL DEPOT GEL | Medpharm Holdings, LLC | CHANDRAKUMAR, NIZAL S | 1625 | §101Other | Final Rejection | 33d | Pending | May 10, 2023 |
| 18020010 | LITHIATED SILICON | King'S College London | LI, JUN | 1732 | §102§103 | Final Rejection | 85d overdue | Pending | Feb 06, 2023 |
| 18161617 | METHODS AND COMPOSITIONS FOR TREATING METABOLIC CONDITIONS | Kemin Industries, Inc. | DICKENS, AMELIA NICOLE | 1645 | §112 | Non-Final OA | — | Pending | Jan 30, 2023 |
| 18084539 | COMPOSITIONS CONTAINING ORGANIC ACIDS AND THEIR ESTERS TO PREVENT MOLD CONTAMINATION IN ANIMAL FEED | Kemin Industries, Inc. | WERTZ, ASHLEE ELIZABETH | 1612 | §103 | Non-Final OA | — | Pending | Dec 19, 2022 |
| 17974506 | COMPOSITIONS FOR INCREASING ETHANOL PRODUCTION AND RELATED METHODS | Kemin Industries, Inc. | JONES-FOSTER, ERICA NICOLE | 1656 | §103 | Final Rejection | — | Pending | Oct 26, 2022 |
| 17947773 | PEA PROTEIN COMPOSITIONS FOR REDUCING FAT ABSORPTION IN FRIED FOOD AND RELATED METHODS | Kemin Industries, Inc. | MORENO, LARK JULIA | 1793 | §103 | Final Rejection | — | Pending | Sep 19, 2022 |
| 17312317 | Screening Assays, Modulators and Modulation of Intracellular Signalling Mediated by Immunoglobulin Superfamily Cell Adhesion Molecules | The University of Western Australia | WU, JULIE ZHEN QIN | 1643 | §102§103§112 | Final Rejection | 12d | Pending | Jun 09, 2021 |
| 17180049 | COMPOSITIONS OF SOLUBLE BETA GLUCAN AND RELATED METHODS | Kemin Industries, Inc. | CRAIGO, BAHAR ALAWI | 1699 | §103Other | Non-Final OA | 16d | Pending | Feb 19, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial89.0% of resolved applications prosecuted by Nyemaster Goode P.C. were allowed, across 1,146 applications in USPTO records.
3.66 office actions per allowed application on average.
28 pending office actions as of October 2026, for 13 clients, before 28 examiners in 23 art units.
